Skip to main content
. 2023 Jan 22;24(3):2181. doi: 10.3390/ijms24032181

Table 2.

Summary of the raw data generated by sequencing of the three groups (mock, ToLCNDV-India, and ToLCNDV-ES).

Index Infected Condition Sample ID Total Read Bases Total Reads GC (%) Q20 (%) Q30 (%)
1 ToLCNDV-ES I-NDV-1-1 4,258,032,538 42,158,738 45.16 98.9 96.45
2 ToLCNDV-ES I-NDV-1-2 4,264,281,004 42,220,604 45.62 98.95 96.54
3 ToLCNDV-ES I-NDV-2-1 3,917,026,238 38,782,438 45.41 98.9 96.41
4 ToLCNDV-ES I-NDV-2-2 3,668,776,722 36,324,522 45.09 98.98 96.54
5 Mock Mock 1-1 3,895,794,422 38,572,222 45 98.89 96.38
6 Mock Mock 1-2 3,596,973,600 35,613,600 44.75 98.89 96.34
7 Mock Mock 2-1 3,797,215,190 37,596,190 44.95 98.84 96.22
8 Mock Mock 2-2 3,931,060,996 38,921,396 45 98.88 96.29
9 ToLCNDV-India Pa-NDV-1-1 3,523,436,914 34,885,514 44.79 97.54 92.9
10 ToLCNDV-India Pa-NDV-1-2 4,123,268,238 40,824,438 44.95 97.74 93.41
11 ToLCNDV-India Pa-NDV-2-1 4,111,628,796 40,709,196 44.98 97.58 93.02
12 ToLCNDV-India Pa-NDV-2-2 3,201,276,608 31,695,808 44.97 97.42 92.7